These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30664724)

  • 1. Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
    Fu H; Zhang X; Han T; Mo X; Wang Y; Chen H; Han W; Wang J; Wang F; Yan C; Zhang Y; Sun Y; Liu K; Huang X; Xu L
    Bone Marrow Transplant; 2019 Aug; 54(8):1310-1318. PubMed ID: 30664724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
    Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
    J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation].
    Ma YR; Huang XJ; Mo XD; Han W; Yan CH; Chen Y; Ji Y; Chen YY; Wang Y; Zhang XH; Liu KY; Xu LP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1065-1069. PubMed ID: 28088971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience.
    Yan F; Lu N; Gu Z; Huang W; Wang S; Gao X; Dou L; Li F; Wang L; Li M; Liu D; Gao C
    Ann Hematol; 2022 Feb; 101(2):397-408. PubMed ID: 34735613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
    Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience.
    Kilic Gunes E; Yigit Kaya S; Yaman F; Yeniay MK; Vural K; Comert M; Sevindik OG; Andic N; Dagdas S; Nizam Ozen I; Kaynar L; Yavasoglu F; Ozet G; Karakus V; Ayli M
    Leuk Res; 2024 May; 140():107484. PubMed ID: 38520796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study.
    Liu L; Han B; Zhang Y; Lei M; Liu R; Lin Z; Jiao W; Zhang F; Fu R; Zhao X; Miao M; Zhang L; Wu D
    Bone Marrow Transplant; 2024 Oct; 59(10):1449-1457. PubMed ID: 39090437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation in children: Single-centre experience.
    Yaman Y; Elli M; Şahin Ş; Özdilli K; Bilgen H; Bayram N; Nepesov S; Anak S
    Pediatr Transplant; 2021 Aug; 25(5):e13962. PubMed ID: 33452850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
    Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
    Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin.
    Li Y; Kong F; Bai G; Jiang Y; Zhang W; Sun X; Sui X; Li Y; Ding M; Yuan D; Wang X; Fang X
    Front Immunol; 2024; 15():1340908. PubMed ID: 38650933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation.
    Zhou M; Li T; Zhang P; Lai Y; Sheng L; Ouyang G
    Ann Hematol; 2024 May; 103(5):1697-1704. PubMed ID: 38536476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children.
    Uria-Oficialdegui ML; Alonso L; Benitez-Carabante MI; Renedo B; Oliveras M; Diaz-de-Heredia C
    Pediatr Transplant; 2021 Jun; 25(4):e14010. PubMed ID: 33742757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.
    Liesveld JL; Phillips GL; Becker M; Constine LS; Friedberg J; Andolina JR; Milner LA; DeBolt J; Smudzin T; Hyrien O; Erickson-Miller CL; Johnson BM; Dawson KL; Chen Y
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1745-52. PubMed ID: 24120380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of eltrombopag plus pulsed dexamethasone as first-line therapy for immune thrombocytopenia.
    Zhang L; Zhang M; Du X; Cheng Y; Cheng G
    Br J Haematol; 2020 Apr; 189(2):369-378. PubMed ID: 31943136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
    Tanaka T; Inamoto Y; Yamashita T; Fuji S; Okinaka K; Kurosawa S; Kim SW; Tanosaki R; Fukuda T
    Biol Blood Marrow Transplant; 2016 May; 22(5):919-24. PubMed ID: 26785333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.
    Masetti R; Vendemini F; Quarello P; Girardi K; Prete A; Fagioli F; Pession A; Locatelli F
    Pediatr Blood Cancer; 2020 May; 67(5):e28208. PubMed ID: 32065469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eltrombopag for Delayed Platelet Recovery and Secondary Thrombocytopenia Following Allogeneic Stem Cell Transplantation in Children.
    Li S; Wu R; Wang B; Fu L; Zhu G; Zhou X; Ma J; Zhang L; Qin M
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):38-41. PubMed ID: 30080752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eltrombopag for treatment of thrombocytopenia-associated disorders.
    Merli P; Strocchio L; Vinti L; Palumbo G; Locatelli F
    Expert Opin Pharmacother; 2015; 16(14):2243-56. PubMed ID: 26364898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
    Oliva EN; Alati C; Santini V; Poloni A; Molteni A; Niscola P; Salvi F; Sanpaolo G; Balleari E; Germing U; Fenaux P; Stamatoullas A; Palumbo GA; Salutari P; Impera S; Avanzini P; Cortelezzi A; Liberati AM; Carluccio P; Buccisano F; Voso MT; Mancini S; Kulasekararaj A; Morabito F; Bocchia M; Cufari P; Spiriti MA; Santacaterina I; D'Errigo MG; Bova I; Zini G; Latagliata R
    Lancet Haematol; 2017 Mar; 4(3):e127-e136. PubMed ID: 28162984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
    Ahmed S; Bashir Q; Bassett RL; Ullah F; Aung F; Valdez BC; Alousi AM; Hosing C; Kebriaei P; Khouri I; Marin D; Nieto Y; Olson A; Oran B; Qazilbash MH; Rezvani K; Mehta R; Shpall EJ; Ciurea S; Andersson BS; Champlin RE; Popat UR
    Am J Hematol; 2024 Apr; 99(4):562-569. PubMed ID: 38314663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.